| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |